Advertisement

Topics

Merz, Inc. Company Profile

16:37 EDT 26th March 2019 | BioPortfolio

Merz, Inc. is a focused specialty healthcare company that is responsible for developing and commercializing innovative products and solutions in neurology, medical aesthetics, and dermatology in the U.S. For more than 100 years, the development of our products has been based on our commitment to innovative medical approaches that earn trust among patients, physicians, customers and partners worldwide. Our ambition is to become a recognized leader in the treatment of movement disorders, as well as aesthetic and dermatologic conditions. Our pipeline is promising, and with new therapeutic options we will continue our commitment to improving patients’ lives.


News Articles [10 Associated News Articles listed on BioPortfolio]

Merz Presents Key Findings Showcasing Five-Year Effectiveness of Cellfina® on Cellulite ...

Merz is also presenting key updates on leading aesthetics products including XEOMIN®, RADIESSE® and DESCRIBE®, with 15 presentations total Read more...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz Delivers Double-Digit Growth in Strategic Business Areas

In fiscal year 2017/18, Aesthetics and Specialty Neurology grew by 19 percent Merz, a global leader in aesthetics and neurotoxins, showed substantial growth across both...

PTV News: Jan 5, 2010

Top stories on January 5th, 2010: Targeting cancer: RNAi minnow in billion plus pact Wrinkle power: Merz’s move into aesthetic medicine Genzyme's "fill and finish" deal with Hospira Action Share...

Merz to Present New Aesthetics Clinical Data at IMCAS 2019

Merz, a global leader in aesthetics and neurotoxins, announced today that clinical data on the use of the Merz Aesthetics portfolio, including Bocouture®, Belotero®, Cellfina®,...

Merz and Christie Brinkley Inspire Women to Redefine Life’s Big Moments Through New “Milestones of Me” Campaign Featuring Ultherapy®

Christie Brinkley Celebrates Her 65th Birthday and Shares How Ultherapy Helps Her Look Her Best for the Moments, Big or Small, that Matter Most Merz Americas is partner...

Merz Pharma GmbH Co KgaA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryMerz Pharma GmbH Co KgaA Merz Pharma is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company's pro...

Merz Presents Data Confirming the Long-Term Efficacy and Safety of XEOMIN® (IncobotulinumtoxinA) for Sialorrhea

Results presented at 2018 AAPM&R Annual Assembly show long-term improvement in adult patients with chronic sialorrhea (or excessive drooling) Merz today announced l...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Naftin [merz pharmaceuticals, llc]

NAFTIN NAFTIFINE HCl 1%

Naftin [physicians total care, inc.]

NAFTIN NAFTIFINE HCl 1% GEL

Naftin [physicians total care, inc.]

NAFTIN NAFTIFINE HCl 1% CREAM

Cuvposa [merz pharmaceuticals, llc]

These highlights do not include all the information needed to use CUVPOSA safely and effectively. See full prescribing information for CUVPOSA. CUVPOSA (glycopyrrolate) oral solution Initial U.S. Appr...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

A Multicenter, Retrospective Evaluation of Tissue Stabilized-Guided Subcision in the Management of Cellulite.

The first FDA-cleared long-lasting, minimally invasive device for improving the appearance of cellulite was recently launched in Canada as a novel tissue stabilized-guided subcision (TS-GS) system (Ce...

Botulinum Toxin Type A: Evaluation of Onset and Satisfaction.

With the increasing interest in nonsurgical cosmetic procedures, this research study sought to evaluate the onset of Botulinum toxin Type A (BoNTA) between naive and non-naive consumers and its effect...

Rescue of Fmr1 phenotypes with mGluR inhibitors: MRZ-8456 versus AFQ-056.

Metabotropic glutamate receptor 5 (mGluR) is a drug target for central nervous system disorders such as fragile X syndrome that involve excessive glutamate-induced excitation. We tested the efficacy o...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation

Primary objective: - To evaluate the sensitivity of the Merz Lip Fullness Assessment Scale (MLFAS). Secondary objectives: - To evaluate the clinical aesthetic improvement outco...

Evaluation of the Merz Cheek Fullness Assessment Scale in the Treatment of Midface Volume Deficit

Evaluation of the sensitivity of the Merz Cheeks Fullness Assessment Scale (MCFAS) and the clinical relevance of aesthetically pleasing outcomes by detecting changes in cheek appearance af...

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...

The Influence of Glutamate on Memory in Humans

The hippocampus is particularly laden with n-methyl-d-aspartate (NMDA) receptors, and is at the same time one of the most important sites in declarative memory. The rationale of this study...

Companies [14 Associated Companies listed on BioPortfolio]

Merz Pharma Canada Ltd.

Merz Pharma Canada Ltd. a wholly owned subsidiary of the Merz Group of Companies was established in 2009 to expand Merz franchises in the Canadian Marketplace.

Merz Pharmaceuticals

Merz Pharmaceuticals, LLC is a part of Merz, Inc., a wholly owned U.S. subsidiary of the Merz Group of Companies and was established in 1995 to develop and commercialize products for the Merz Group. ...

Merz Aesthetics

Merz Aesthetics, the new business unit of Merz Pharma Group, is a leader in the global aesthetic medicine market. With a 100-year history of compassion and innovation in healthcare, Merz Aesthetics i...

Merz Pharmaceuticals GmbH and DiaGenic ASA

Merz Pharmaceuticals researches, develops, produces and distributes innovative pharmaceutical products in the areas of neurology and psychiatry as well as in aesthetic dermatology and metabolism. ...

Merz Neurosciences

Merz Neurosciences is a division of Merz North America, a specialty healthcare company that develops and commercializes treatment solutions in aesthetics, dermatology and neurosci...

More Information about "Merz, Inc." on BioPortfolio

We have published hundreds of Merz, Inc. news stories on BioPortfolio along with dozens of Merz, Inc. Clinical Trials and PubMed Articles about Merz, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merz, Inc. Companies in our database. You can also find out about relevant Merz, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record